Raymond James starts Palisade Bio (PALI) at Outperform, $6 target
Raymond James initiated coverage of Palisade Bio (PALI) with an Outperform rating and a $6 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.